
COVID And Aduhelm On The Agenda At Denver Alzheimer's Meeting
Short Wave
00:00
Cognitive Health Post-COVID and Aduhelm Controversy
This chapter explores the lasting cognitive effects of COVID-19 and introduces Aduhelm, a controversial Alzheimer's drug facing scrutiny over its approval and safety. Experts discuss the ethical implications of its use, potential side effects, and the importance of rigorous patient evaluations before treatment.
Play episode from 06:06
Transcript


